Skip to main content
CNTX
NASDAQ Life Sciences

CTIM-76 Shows 22% ORR in Platinum-Resistant Ovarian Cancer as Cash Runs to Early Q4 2027

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.188
Mkt Cap
$17.181M
52W Low
$0.18
52W High
$3.62
52W Position info
4.2% above low
Off High info
95% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

CNTX is trading near its 52-week low of $0.18 (4.2% above the low).

Summary

Context reported Q3 2026 results alongside longer-term Phase 1 data for CTIM-76, its CLDN6 x CD3 T cell engager. In nine efficacy-evaluable platinum-resistant ovarian cancer patients dosed weekly at 140–280 µg, confirmed ORR was 22% and DCR 56%, with median PFS of 5.6 months — a meaningful benchmark given patients had a median of six prior lines of therapy and 80% had prior ADC exposure. Liver metastases responded too: all seven target lesions shrank, two disappearing entirely. Safety was manageable at active doses, with Grade 1/2 CRS in 18.5% of 27 patients and dose-related Grade ≥3 liver enzyme elevations that resolved on continued dosing. Cash of $34.4M at September 30 funds operations into early Q4 2027, and the company guided to Phase 1b initiation in Q1 2027 with initial every-three-week efficacy data in Q2 2027. The Q3 net loss narrowed to $7.6M from $9.7M a year ago on lower CT-202 spending. The stock trades near its 52-week low, so the data readout and runway extension are the two things that matter here.

At the time of this announcement, CNTX was trading at $0.19 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $17.2M. The 52-week trading range was $0.18 to $3.62. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CNTX - Latest Insights

CNTX
Nov 10, 2026, 4:12 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1875
Real-time Price: $0.1986 info
Change: +$0.0111 (+6%) info
Market Cap: $18.247M info
CNTX
Aug 06, 2026, 1:32 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $0.482
Real-time Price: $0.1986 info
Change: -$0.2834 (-59%) info
Market Cap: $18.247M info
CNTX
Aug 05, 2026, 4:58 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.660
Real-time Price: $0.1986 info
Change: -$0.4614 (-70%) info
Market Cap: $18.247M info
CNTX
Jul 31, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.5994
Real-time Price: $0.1986 info
Change: -$0.4008 (-67%) info
Market Cap: $18.247M info
CNTX
Jun 26, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.570
Real-time Price: $0.1986 info
Change: -$0.3714 (-65%) info
Market Cap: $18.247M info